Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.
  • RangerJosey@lemmy.mlEnglish
    2·
    1 month ago

    I’d love to know my roots. But I don’t want to be in those databases when they’re eventually used against us and/or for evil.